Tamoxifen enhances stemness and promotes metastasis of ERα36+ breast cancer by upregulating ALDH1A1 in cancer cells-Reference-Cited by-同舟云学术

Tamoxifen enhances stemness and promotes metastasis of ERα36+ breast cancer by upregulating ALDH1A1 in cancer cells

Published:2018-02-02 Issue:3 Volume:28 Page:336-358
ISSN:1001-0602
Container-title:Cell Research
language:en
Short-container-title:Cell Res

Author:

Wang Qiang,Jiang Jun,Ying Guoguang,Xie Xiao-Qing,Zhang Xia,Xu Wei,Zhang Xuemin,Song Erwei,Bu Hong,Ping Yi-Fang,Yao Xiao-Hong,Wang Bin,Xu Shilei,Yan Ze-Xuan,Tai Yanhong,Hu Baoquan,Qi Xiaowei,Wang Yan-Xia,He Zhi-Cheng,Wang Yan,Wang Ji Ming,Cui You-Hong,Chen Feng,Meng Kun,Wang Zhaoyi,Bian Xiu-Wu

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/cr201815.pdf

Reference71 articles.

1. CTSU RI . Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365:1687–1717.

2. Johnston SR . New strategies in estrogen receptor-positive breast cancer. Clin Cancer Res 2010; 16:1979–1987.

3. Ali S, Coombes RC . Endocrine-responsive breast cancer and strategies for combating resistance. Nat Rev Cancer 2002; 2:101–112.

4. Burstein HJ, Prestrud AA, Seidenfeld J, et al. American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol 2010; 28:3784–3796.

5. Davies C, Godwin J, Gray R, et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 2011; 378:771–784.

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bio-Pathological Functions of Posttranslational Modifications of Histological Biomarkers in Breast Cancer;Molecules;2024-09-02

2. ALDH1A1 promotes immune escape of tumor cells through ZBTB7B-glycolysis pathway;Cell Death & Disease;2024-08-07

3. APOA5 alleviates reactive oxygen species to promote oxaliplatin resistance in PIK3CA-mutated colorectal cancer;Aging;2024-06-06

4. Resonance of fatty acid metabolism and immune infiltration in anti-PD-1 monotherapy for breast cancer;Translational Oncology;2024-06

5. Estrogen Receptor Alpha Mutations, Truncations, Heterodimers, and Therapies;Endocrinology;2024-04-21